The case dates to July 2019, when breast specialist Claire Hanley, MD, first filed suit against New York City Health and Hospitals Corp. 

Rads and other physicians have roundly criticized the change, labeling the policy as “deeply flawed and operationally unworkable.” 

Effective Dec. 10, Brett Brodnax, Bridget Karlin, Matthew Lungren, MD, and Robert Mittl, MD, joined Lumexa’s board of directors.